Promising results from an early-stage trial suggest that lenacapavir injections might offer long-lasting protection.

The scientist who was jailed for three years for performing illegal gene-altering on babies has criticized ethics for slowing ...

The scientist who went to prison for gene hacking a pair of twins in China is now decrying the ethics that punished him.

US biotech Excision BioTherapeutics has raised $60 million to test a potential HIV cure in the clinic, which would use CRISPR technology to snip out the viral code from human cells and tissues.

Bioengineering professor and The Grainger College of Engineering's Dean, Rashid Bashir, led a team of researchers in a ...

University of Illinois at Urbana-Champaign researchers have developed a CRISPR-based diagnostic tool capable of detecting ...

Promising results from an early-stage trial suggest that lenacapavir injections might offer long-lasting protection. What will really matter in the long run? That’s the question we tackle each year as ...

Last year, Gilead released data showing that an HIV drug, called lenacapavir, could provide virtually complete protection against infection with just a single injection every six months.

Feb. 18, 2025 — Viruses, like those that cause COVID-19 or HIV, are formidable opponents once they invade our bodies. Antiviral treatments strive to block a virus or halt its replication.

Researchers at National Taiwan University have unveiled an innovative diagnostic tool that significantly improves the speed ...

It’s possible that HIV could be prevented by an annual shot — at least, that’s what new data from Gilead suggests. The drug company has been developing a new HIV drug called lenacapavir ...